SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Mike Grey will be speaking on a panel, Driving Life Sciences Discovery in 2011 and Beyond: Acquire or Partner? at BIOCOMS May breakfast meeting, San Diego CA.
News | 05. 04. 2011
